セッション詳細
[WS(O)11]Tumor microenvironment and biomarkers
2024年12月3日(火) 15:25 〜 16:40
Room C
Organizers: Yosuke Togashi (Okayama University), Tomoko Hirano (Kyoto University)
[WS11-01-O/P]Sympathetic Nerve Ablation Impact on Angiogenesis and Antitumor Immunity in Hepatocellular Carcinoma
○Chen Sun1, Yuqing Shen1, Fuhua Wang1, Tian Lu1, Jianqiong Zhang1,2 (1.Department of Microbiology and Immunology, Medical School, Southeast University, Jiangsu Province, China, 2.Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Zhongda Hospital, Southeast University, Nanjing, China)
[WS11-02-O/P]Single cell immunoprofiling of tumor infiltrating T cells in renal cell carcinoma
○Taku Kouro1,2, Mitsuru Komahashi1,3, Shun Horaguchi1,3, Kayoko Tsuji1, Rika Kasajima4, Tetsuro Sasada1,2 (1.Div. Cancer Immunotherapy, Kanagawa Cancer Center Research Institute, 2.Cancer Vaccine and Immunotherapy Center, Kanagawa Cancer Center, 3.Department of Pediatric Surgery, Nihon University School of Medicine, 4.Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute)
[WS11-03-O/P]Elucidating the Immune Microenvironment of Multiple Myeloma Through Advanced Multi-Omics Analysis
○Shangru Jia1, Alok Sharma2,3,4, Artem Lysenko2,3, Keith Boroevich3, Tatsuhiko Tsunoda1,2,3 (1.Tsunoda Lab, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Japan, 2.Laboratory for Medical Science Mathematics, Department of Biological Sciences,School of Science, The University of Tokyo, Japan, 3.Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Japan, 4.Institute for Integrated and Intelligent Systems, Griffith University, Nathan, Brisbane, QLD4111, Australia)
[WS11-05-O/P]ADAM9 drives immune suppression in the lung cancer microenvironment
○Yuh Pyng Sher1, Jing Pei Liu1, Shih Jen Liu2 (1.China Medical University, 2.National Health Research Institutes)
[WS11-07-O/P]Combination of plasma MMPs and PD-1-binding soluble PD-L1 as a non-invasive tool to predict recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer
○Fumihiko Ando1,2, Takeru Kashiwada3, Shoko Kuroda1, Ryotaro Takano1,2, Yoshishige Miyabe1,4, Tomoko Asatsuma-Okumura1, Masahiro Seike3, Yoshiko Iwai1 (1.Department of Cell Biology, Institute of Advanced Medical Sciences, Nippon Medical School, 2.Department of Gastroenterological Surgery, Nippon Medical School, 3.Department of Pulmonary Medicine and Oncology, Nippon Medical School, 4.Department of Immunology and Parasitology, St. Marianna University School of Medicine)
[WS11-12-O/P]Membrane-based RNA sequencing to analyze the interaction between cancer cells and immune cells
○Tadashi Imafuku, Sadahiro Iwabuchi, Shinichi Hashimoto (Wakayama Medical University)
[WS11-14-O/P]Genetically encoded fluorescent lactate biosensors for investigating tumor-immune microenvironment
○Yusuke Nasu1,2, Yuki Kamijo1 (1.Department of Chemistry, School of Science, The University of Tokyo, 2.Japan Science and Technology Agency)